Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Jongs N, Greene T, Chertow GM, et al.
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00243-6.
Leggi


